Interventional Cardiology clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
open to eligible people ages 18-90
The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercially available Impella systems (comparator device).
Sacramento, California and other locations
Our lead scientists for Interventional Cardiology research studies include Garrett Wong, M.D..
Last updated: